In the News Stocks: Chimerix (NASDAQ:CMRX), BankUnited (NYSE:BKU), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), United States Steel Corp. (NYSE:X)

Limelight Networks, Inc. (NASDAQ:LLNW) shares fell -1.86% in last trading session and ended the day at $2.11. LLNW Gross Margin is 40.40% and its has a return on assets of -9.20%. Limelight Networks, Inc. (NASDAQ:LLNW) quarterly performance is -48.28%.

On 28 September, Limelight Networks, Inc. (NASDAQ:LLNW), announced the Limelight OrchestrateTM (“Orchestrate”) Video service is helping the Described and Captioned Media Program (DCMP) to efficiently and cost-effectively deliver accessible media to visually and/or hearing impaired K-12 students worldwide.

Chimerix, Inc. (NASDAQ:CMRX) ended the last trading day at $37.11. Company weekly volatility is calculated as 8.26% and price to cash ratio as 6.62. Chimerix, Inc. (NASDAQ:CMRX) showed a weekly performance of 1.89%.

On 21st September, it was reported Chimerix, Inc. (NASDAQ:CMRX), presented findings from a new study that show hospital readmissions related to opportunistic infections are common among patients following autologous and allogeneic hematopoietic cell transplant (HCT), also known as bone marrow or stem cell transplant. The study showed that of hospital readmissions related to opportunistic infections (25.8 percent of all readmissions), approximately 1 in 3 readmissions were due to double-stranded DNA (dsDNA) viral infections. Among dsDNA viral infections diagnosed after hospital discharge, almost half occurred within the first month after discharge.

On 06 October, BankUnited, Inc. (NYSE:BKU) shares fell -0.61% and was closed at $35.75. BKU EPS growth in last 5 year was 8.80%. BankUnited, Inc. (NYSE:BKU) year to date (YTD) performance is 25.67%.

BankUnited, Inc. (NYSE:BKU) announced that its Board of Directors has declared a quarterly cash dividend of $0.21 per common share. The dividend will be payable on October 15, 2015 to stockholders of record at the close of business on October 1, 2015.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares fell -4.42% in last trading session and ended the day at $109.46. VRTX Gross Margin is 92.60% and its has a return on assets of -31.60%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) quarterly performance is -9.94%.

On 25 September, Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced that the European Union Committee for Medicinal Products for Human Use (CHMP) issued a positive Opinion recommending Marketing Authorization of ORKAMBI™ (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people ages 12 and older with two copies of the F508del mutation. In Europe, approximately 12,000 people with CF ages 12 and older have two copies of this mutation.

United States Steel Corp. (NYSE:X) caters to the Basic Materials space. It has a net profit margin of -1.80% and weekly performance is 12.92%. On the last day of trading company shares ended up at $11.80. United States Steel Corp. (NYSE:X) distance from 50-day simple moving average (SMA50) is -24.79%.

The United States Steel Corporation (NYSE:X) is examining consolidation of its North American Flat-Rolled operations. This may temporarily idle operations at the Granite City plant. The company says they, “routinely adjusts production at its operating facilities to reflect market fluctuations. The potential consolidation is a result of continued challenging global market conditions including fluctuating oil prices, reduced rig counts, depressed steel prices and unfairly traded imports.”